glp 1 thyroid nodule GLP-1 Receptor Agonists and Cancer Risk, Rodent Data and FDA Warning, • In rodents, GLP-1 receptor agonists (GLP-1 RAs) stimulate thyroid C-cells, increasing the incidence of medullary thyroid Do GLP-1s cause thyroid cancer?

A 2025 retrospective analysis published in Ophthalmology Retina evaluated the incidence of DME among patients with type 2 diabetes who took various classes of medications

This would be especially true for drugs relying on a fine functional remodulation of a well preserved cellular system, like the NRF2 activators on the KEAP1-NRF2 system

Storage considerations: Lyophilized storage at 20 C supports stability

The reason tirzepatides effect on out-of-control eating was only temporary in this case is likely because the drug was designed and optimized for diabetes and weight loss, not for binge-eating disorders, Halpern surmised